Supplemental training

  Create an account or log in to participate in this activity

Educational Objectives

At the conclusion of this activity, participants should be better able to:

1. Describe the potential benefits and risks of the interventional pain management procedures
2. Describe specific pain conditions which are most likely to respond to the interventional pain management procedures
3. Set realistic expectations for patients being referred to a pain management specialist

Accreditation

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

Boston University Chobanian & Avedisian School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Support

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Disclosure Policy

Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

Faculty

Daniel P. Alford, MD, MPH (CME Course Director)
Professor of Medicine
Associate Dean, Center for Continuing Education
Boston University Chobanian & Avedisian School of Medicine
Boston Medical Center

Ail Ebrahimi, MD, BSc
Medical Staff
Department of Anesthesia and Pain Medicine
Massachusetts General Brigham Hospital
Boston, Massachusetts

Faculty members have no relevant relationships to disclose. Faculty members do not plan on discussing unlabeled/investigational uses of a commercial product.

Planning Committee

Ilana Hardesty, Assistant Director, Operations, Center for Continuing Education, Boston University Chobanian & Avedisian School of Medicine, has no relevant financial relationships to disclose.

Date of Release: March 27, 2025
Date of Expiration: March 26, 2026

Disclaimer

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.